Clinical trial Recruiting at 3 sites Interventional Ages 18 and up

Minimally invasive Ennovate® method for cervical pedicle screw placement

Official title: Controlled, Randomized Clinical Study to Demonstrate the Patient Benefit and Safety of Pedicle Screw Placement Through an Innovative Minimally Invasive Surgical Approach Using the Ennovate® Cervical Spinal System

Run by Aesculap AG · NCT06960018 · Data updated 2026-11-12

This project tests whether the minimally invasive Ennovate® method for placing cervical pedicle screws is safe and helps adults who need posterior cervical fusion.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment76 (estimated)
SponsorAesculap AG
Industry-sponsored
Locations3 sites (Aachen and 2 other locations)
StatusRecruiting
StartedJune 20, 2025
Main results expectedNovember 2027
Study endsNovember 2028
Registry record updatedApril 15, 2026
Trial IDNCT06960018 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults 18 or older scheduled to receive Ennovate® Cervical internal fixation between C2 and Th3 for restoration and stabilization of the cervical spine who can provide consent and attend routine follow-up are ideal candidates.

Probably not a fit

Patients with severe bone disorders (for example severe osteoporosis or Paget's disease), active vertebral infection, suspected allergy to implant materials, or those unable to comply with follow-up are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The study collects clinical data comparing a minimally invasive Ennovate® cervical pedicle screw technique to the standard open surgical approach for posterior cervical fusion. Adult patients (age ≥18) receiving Ennovate® Cervical internal fixation between C2 and Th3 will be enrolled and followed for safety, implant stability, and recovery outcomes. Surgeons will use either the minimally invasive or open technique with the Ennovate® Cervical Spinal System and outcomes will include complication rates, radiographic stability, and patient-centered measures such as pain and return to function. Routine postoperative follow-up visits will capture clinical and device-related data to inform benefit and risk profiles.

Why it matters

Potential benefit: If successful, the minimally invasive approach could reduce tissue damage, shorten hospital stays, and speed recovery while maintaining spinal stability.

How similar studies have gone: Minimally invasive pedicle screw techniques elsewhere in the spine have shown reduced blood loss and faster recovery, but minimally invasive cervical pedicle fixation with the Ennovate® method is relatively novel and has limited published clinical data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* All patients with minimum 18 years of age receiving Ennovate® Cervical internal fixation device within the vertebral bodies C2-Th3 to ensure the restoration and stabilization of the cervical spine

Exclusion Criteria:

* All patients not willing to sign the patient consent are excluded. Also, if it is clear from the beginning, that the patient will not be able to come to routine follow-up, the patient will also be excluded.

Absolute contraindications according to the IFU:

* Severe damage to the bone structures of the spine that could prevent the stable implantation of the implant components; for example, osteopenia, severe osteoporosis, Paget's disease, bone tumors etc.
* Metabolic or degenerative metabolic bone diseases that could compromise the stable anchoring of the implant system.
* Suspected allergy or sensitivity to the implant materials.
* Acute or chronic vertebral infections of a local or systemic nature.
* Poor patient compliance or limited ability to follow medical instructions, particularly in the postop phase, including with regard to the restrictions on range of movement in terms of physical exercise and occupational activity.

Where it's running

  • Universitätsklinikum Aachen
    Aachen, Germany
    Recruiting
  • Charité Berlin
    Berlin, Germany
    Recruiting
  • Universitätsklinikum Freiburg
    Freiburg im Breisgau, Germany
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.